Statute of Limitations Tolling for Latent Injuries

Introduction

A statute of limitations prescribes the period within which a person must initiate legal proceedings after suffering an injury or experiencing a violation of legal rights. However, certain injuries remain hidden for months or years. These are known as latent injuries. Examples include genetic mutations, occupational diseases, exposure-related cancers, delayed complications of medical treatment and injuries caused by defective biotechnology products.

The central legal question is: when should the limitation period begin—when the harmful act occurs, when the injury develops, or when the injured person discovers the injury and its possible cause? This issue is particularly important in biotechnology litigation because genetic and environmental injuries may become identifiable only after a considerable period.

1. Meaning of Limitation Tolling

Tolling means suspending or postponing the running of a limitation period in circumstances recognised by law. In latent-injury cases, the discovery principle may be relevant: limitation may begin when the injured person discovers, or reasonably ought to discover, the injury and its legally relevant cause.

However, Indian law does not provide a universal discovery rule for every latent personal injury. The applicable starting date depends on the relevant statutory provision, the nature of the claim and the facts of the case.

2. Indian Legal Framework

The Limitation Act, 1963 provides the principal framework:

Section 3: Requires courts to dismiss proceedings instituted after the prescribed limitation period, subject to statutory exceptions.

Section 5: Permits condonation of delay for appeals and applications on sufficient cause; it does not generally extend limitation for institution of suits.

Section 17: Postpones commencement of limitation in specified cases involving fraud, concealment of rights, mistake or fraudulent concealment of necessary documents, until discovery or the point when discovery was reasonably possible.

Section 22: Provides a fresh limitation period at every moment during which a continuing breach or continuing tort persists.

Article 113: Prescribes three years for suits where no specific limitation period is provided, beginning when the right to sue accrues.

For consumer disputes, Section 69 of the Consumer Protection Act, 2019 generally provides two years from the date the cause of action arises, subject to condonation for sufficient cause.

IndiaCode+2

3. Important Case Laws

1. V.N. Shrikhande v. Anita Sena Fernandes, (2011) 1 SCC 53: The Supreme Court examined limitation in a medical negligence complaint involving a foreign object allegedly left inside a patient's body after surgery. The decision emphasises that limitation must be assessed with reference to when the cause of action arose and the circumstances of the patient's knowledge. It is relevant to delayed-discovery claims, but does not establish an unrestricted discovery rule for every medical injury.

2. Khatri Hotels Pvt. Ltd. v. Union of India, (2011) 9 SCC 126: The Supreme Court explained that, under Article 58 of the Limitation Act, limitation begins when the right to sue first accrues. A claimant cannot repeatedly postpone limitation merely because the consequences of an earlier infringement continue.

Sci API

3. M.R. Gupta v. Union of India, (1995) 5 SCC 628: The Court distinguished a continuing wrong from the continuing effects of a completed wrong. Where an incorrect pay fixation causes recurring underpayments, a fresh cause of action may arise with each affected payment. This distinction is useful when evaluating continuing exposure or recurring injury claims.

4. P. Radha Bai v. P. Ashok Kumar, (2019) 13 SCC 445: The Supreme Court clarified that Section 17 requires discovery of fraud or mistake, or the point at which it could have been discovered through reasonable diligence. It also held that Section 17 does not extend the special limitation period under Section 34(3) of the Arbitration and Conciliation Act, 1996.

IndiaCode+1

4. Application to Genetic and Biotechnological Injuries

Suppose a person is exposed to a harmful chemical used in genetic research in 2018 but discovers a genetic abnormality in 2024. The person may argue that the injury was latent and could not reasonably have been identified earlier.

A court would examine:

When the exposure occurred and when the injury actually developed.

When medical testing first revealed the genetic abnormality.

Whether the claimant could reasonably have discovered the injury earlier.

Whether the defendant concealed relevant research findings or medical information.

Whether the alleged injury resulted from a continuing harmful activity or a completed past exposure.

If the defendant deliberately conceals evidence of the harmful exposure, Section 17 may become relevant, provided its statutory requirements are established. However, delayed discovery alone does not automatically suspend limitation.

5. Continuing Injury and Latent Injury: Legal Distinction

A continuing injury is not necessarily a continuing wrong. For example, a genetic mutation caused by a single exposure may produce medical consequences for several years. Those continuing consequences do not automatically create a fresh limitation period every day.

By contrast, if a factory continues releasing harmful substances and causes ongoing exposure, Section 22 may become relevant. Courts must distinguish the continuing wrongful conduct from the continuing effects of an earlier completed act.

6. Legal Challenges and Conclusion

The principal difficulty in latent-injury litigation is determining the precise date on which the cause of action arose. Medical uncertainty, delayed diagnosis, concealed scientific information and long-term genetic consequences make this determination complicated. Defendants may argue that the limitation period began with the original exposure, whereas claimants may argue that the injury was not reasonably discoverable until later.

Indian courts should therefore examine medical records, scientific evidence, expert opinions, exposure histories and evidence of concealment. The discovery of an injury must be distinguished from merely learning that an earlier event may have caused it.

In conclusion, limitation tolling for latent injuries protects individuals who could not reasonably identify their injuries within the ordinary limitation period. The Limitation Act, 1963, particularly Sections 17 and 22, provides limited statutory protection, while judicial decisions clarify the distinction between delayed discovery, continuing wrongs and continuing consequences. There is no blanket exemption from limitation for genetic or biotechnology-related injuries. A claimant must establish the applicable statutory basis and relevant facts before a court can postpone or extend the limitation period.